A Reticulocyte Count Blood Test is used to evaluate erythropoietic activity which is increased in acute and chronic hemorrhage and hemolytic anemias, and evaluate erythropoietic response to antianemic therapy. This test is an indicator that additional testing is necessary to monitor the return of normal bone marrow.